Position in AMGN
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$45,265
+$1,284 QoQ
Shares Held
125
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#3,005
of 3,139 holders
Holding Since
Mar 2023
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Strategic Investment Solutions, Inc. /IL holds $2,503,960 across 13 Drug Manufacturers - General names. AMGN ranks #8 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
929 | $1,114,267 | |
| 2 | AZN |
Astrazeneca PLC
|
2,288 | $433,850 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,899 | $372,520 | |
| 4 | JNJ |
Johnson & Johnson
|
854 | $216,887 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
2,031 | $117,024 | |
| 6 | PFE |
Pfizer Inc
|
4,555 | $109,679 | |
| 7 | ABBV |
AbbVie Inc.
|
195 | $49,068 | |
| 8 | AMGN |
Amgen Inc
This page
|
125 | $45,265 |
All Filings in AMGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,265 | 125 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $43,981 | 125 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $8,182 | 25 | Shares | Sole | 2026-02-27 | |
| 2025-09-30 | $7,055 | 25 | Shares | Sole | 2025-12-03 | |
| 2025-06-30 | $6,980 | 25 | Shares | Sole | 2025-07-16 | |
| 2023-12-31 | $32,834 | 114 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,939,060 | 7,215 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $25,310 | 114 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $27,559 | 114 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||